BACKGROUND: Complement receptor type 1 (CR1), which bears the Knops (Kn [KN]) blood group antigens, is involved in the rosetting of Plasmodium falciparum- infected RBCs with uninfected cells. As a first step in understanding this interaction, the molecular basis for the blood group antigens encoded by CR1 was investigated. STUDY DESIGN AND METHODS: An antibody from a white donor who exhibited an apparent anti-Sl(a) was used for population studies of several racial groups. The donor's genomic DNA was sequenced to identify the Sl(a) mutation and other mutations. RESULTS: The donor with anti-Sl(a) typed as Sl(a+) with some sera and had the CR1 genotype AA at bp 4828 (R1601). However, she was homozygous for a new mutation (GG) at bp 4855 changing amino acid 1610 from S1610 to T1610 (S1610T). This mutation occurred in heterozygous form in eight white and one Asian donor. The site is only nine amino acids from the previously described Sl(a) polymorphism and appears to produce a new conformational epitope. CONCLUSION: The antigen formerly known as Sl(a) can now be subdivided. A new terminology is proposed that recognizes both linear and conformational epitopes on the CR1 protein. At amino acid 1601, Sl 1 (Sl(a)) is represented by R, Sl 2 (Vil) is represented by glycine, and Sl 3 requires both R1601 and S1610. Sl 4 and Sl 5 are hypothetical epitopes represented by S1610 and T1610, respectively.
BACKGROUND: Complement receptor type 1 (CR1), which bears the Knops (Kn [KN]) blood group antigens, is involved in the rosetting of Plasmodium falciparum- infected RBCs with uninfected cells. As a first step in understanding this interaction, the molecular basis for the blood group antigens encoded by CR1 was investigated. STUDY DESIGN AND METHODS: An antibody from a white donor who exhibited an apparent anti-Sl(a) was used for population studies of several racial groups. The donor's genomic DNA was sequenced to identify the Sl(a) mutation and other mutations. RESULTS: The donor with anti-Sl(a) typed as Sl(a+) with some sera and had the CR1 genotype AA at bp 4828 (R1601). However, she was homozygous for a new mutation (GG) at bp 4855 changing amino acid 1610 from S1610 to T1610 (S1610T). This mutation occurred in heterozygous form in eight white and one Asian donor. The site is only nine amino acids from the previously described Sl(a) polymorphism and appears to produce a new conformational epitope. CONCLUSION: The antigen formerly known as Sl(a) can now be subdivided. A new terminology is proposed that recognizes both linear and conformational epitopes on the CR1 protein. At amino acid 1601, Sl 1 (Sl(a)) is represented by R, Sl 2 (Vil) is represented by glycine, and Sl 3 requires both R1601 and S1610. Sl 4 and Sl 5 are hypothetical epitopes represented by S1610 and T1610, respectively.
Authors: P A Zimmerman; J Fitness; J M Moulds; D T McNamara; L J Kasehagen; J Alexandra Rowe; A V S Hill Journal: Genes Immun Date: 2003-07 Impact factor: 2.676
Authors: Brendan T Keenan; Joshua M Shulman; Lori B Chibnik; Towfique Raj; Dong Tran; Mert R Sabuncu; April N Allen; Jason J Corneveaux; John A Hardy; Matthew J Huentelman; Cynthia A Lemere; Amanda J Myers; Anne Nicholson-Weller; Eric M Reiman; Denis A Evans; David A Bennett; Philip L De Jager Journal: Hum Mol Genet Date: 2012-02-17 Impact factor: 6.150
Authors: Helle H Hansson; Jørgen A Kurtzhals; Bamenla Q Goka; Onike P Rodriques; Francis N Nkrumah; Thor G Theander; Ib Christian Bygbjerg; Michael Alifrangis Journal: Malar J Date: 2013-11-07 Impact factor: 2.979
Authors: Thaisa Lucas Sandri; Selorme Adukpo; Dao Phuong Giang; Christian N Nguetse; Fabiana Antunes Andrade; Hoang van Tong; Nguyen Linh Toan; Le Huu Song; Preetham Elumalai; Kumarasamy Thangaraj; Vijaya Lakshmi Valluri; Francine Ntoumi; Christian G Meyer; Iara Jose de Messias Reason; Peter G Kremsner; Thirumalaisamy P Velavan Journal: PLoS One Date: 2017-05-17 Impact factor: 3.240
Authors: J M Moulds; B J Thomas; O Doumbo; D A Diallo; K E Lyke; C V Plowe; J A Rowe; D J Birmingham Journal: Transfusion Date: 2004-02 Impact factor: 3.157
Authors: William J Lane; Connie M Westhoff; Jon Michael Uy; Maria Aguad; Robin Smeland-Wagman; Richard M Kaufman; Heidi L Rehm; Robert C Green; Leslie E Silberstein Journal: Transfusion Date: 2015-12-03 Impact factor: 3.157